DETTY JAMES: Open Payments
NPI 1396488649 · SUFFERN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 21 payments from 9 companies in 2025. Trend: 2023 $49 · 2024 $419 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| Celgene Corporation | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| PFIZER INC. | 3 | $54 |
| Daiichi Sankyo Inc. | 1 | $30 |
| BridgeBio Pharma, Inc. | 1 | $28 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: LEQVIO, ELIQUIS, CAMZYOS, WAINUA, INJECTAFER, Attruby, FUROSCIX, VERQUVO.
Industry payments across NY — which companies pay providers there.
